Original Publication Date: 26 November, 2015
Publication / Source: Nanomedicine
Authors: Deniz Ali Bölükbas & Silke Meiners
Lung cancer is by far the most common cause of cancer-related deaths in the world. Nanoparticle-based therapies enable targeted drug delivery for lung cancer treatment with increased therapeutic efficiency and reduced systemic toxicity. At the same time, nanomedicine has the potential for multimodal treatment of lung cancer that may involve ‘all-in-one’ targeting of several tumor-associated cell types in a timely and spatially controlled manner.